Moolec Science (NASDAQ:MLEC) Upgraded to “Sell” at Wall Street Zen

Wall Street Zen upgraded shares of Moolec Science (NASDAQ:MLEC) to a sell rating in a report issued on Saturday.

Moolec Science Trading Down 13.2%

Shares of MLEC opened at $13.30 on Friday. Moolec Science has a 12 month low of $3.08 and a 12 month high of $157.05. The firm’s 50 day moving average is $6.93 and its 200-day moving average is $11.45. The stock has a market capitalization of $9.71 million, a PE ratio of -0.40 and a beta of -0.46.

Institutional Trading of Moolec Science

An institutional investor recently bought a new position in Moolec Science stock. Citadel Advisors LLC purchased a new position in Moolec Science SA (NASDAQ:MLEC) during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 36,218 shares of the company’s stock, valued at approximately $36,000. Citadel Advisors LLC owned 0.90% of Moolec Science as of its most recent filing with the Securities and Exchange Commission (SEC). Institutional investors and hedge funds own 0.07% of the company’s stock.

Moolec Science Company Profile

Moolec Science SA, a science-based food ingredient company, focuses on developing real animal proteins in plants using molecular farming. It offers Chymosin SPC, a dairy ingredient; GLA SONOVA, a nutritional oil; POORK+, a plant-based, animal meat free ingredient with porcine proteins in soybeans; and BEEF+, a meat replacement product. It operates in the United States, Europe, and South America. The company was founded in 2020 and is based in Luxembourg.